What's new

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 10, Status: Authorised

Mar 26, 2025 - 17:21
 0
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, ...

Next Article

‘Great promise’ for AI-assisted clinical decision-making

Related Posts

Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

EMEA-003488-PIP01-23

EMEA-003488-PIP01-23

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0